News at CenExel
CenExel Psychedelic Facilitators Undergoing Premier Certification Training
Our Clinical Sciences team, comprised of Dr. Larry Ereshefsky, Dr. Brett English, Dr. Robert Litman, along with Principal Investigators Dr. Djouher Hough, and Dr. Haig Goenjian, have developed fit for purpose go-to-clinic strategies encompassing pharmacology, regulatory, and protocol-development consultation services, as well as meticulous clinical trial execution.
Placebo-Control Reminder Script
General medicine studies are not immune to the placebo effect, where 30-40% of patients report improved subjective and objective outcomes in general medical studies (Hrobjartsson & Gotzsche, 2001). The high placebo response has been shown to be increasing as time progresses (Kemp et al., 2010; Loebel et al., 2010; Rief et al., 2009; Tuttle et al., 2015), with such ramifications as several pharma companies reducing or closing their psychiatric as well as general medicine R&D, increased costs for drug development, more inconclusive and failed trials, and delays in the development of new medications (Alphs et al., 2012).
Brandy Isaacks Joins CenExel as Vice President of Project Management & Scientific Affairs
Salt Lake City, October 20, 2022 /GlobeNewswire/ — CenExel announced that Brandy Isaacks has joined their team as Vice President of Project Management and Scientific Affairs. Brandy’s responsibilities will include providing project management coordination and support...
Characterizing human abuse potential (HAP) liability
Characterizing human abuse potential liability can be dependent on many factors, including pharmacology, pharmacokinetics, and the intended population. We can help.
CenExel Acquires Apex Innovative Sciences
Salt Lake City, June 16, 2022 /GlobeNewswire/ — CenExel announces the acquisition of Apex Innovative Sciences, parent company of Collaborative Neuroscience Research (CNS) and Hassman Research Institute (HRI), which will be renamed as “CenExel CNS” and “CenExel HRI”,...
CenExel Acquires iResearch
Salt Lake City, May 3, 2022 /GlobeNewswire/ — CenExel announces the acquisition of iResearch (“CenExel iResearch”), a leading multi-specialty research site business with locations in Decatur, GA and Savannah, GA. CenExel iResearch has deep experience conducting Phase...
Healthy Feet Are Happy Feet-Preventing and Treating Bunions and Ingrown Toenails
As a CenExel Center of Excellence, JBR works with patients who are managing challenging conditions, such as bunions. As a medical researcher in pain management, I have worked with many individuals that have participated in a bunion surgery at our surgical center in SLC, UT, and over the years I have developed a list of preventative treatments that I recommend to patients after surgery to help them keep their feet and toes happy and healthy. Here are my top tips for healthy feet . . .
CenExel Clinical Research Acquires Rocky Mountain Movement Disorders Center
Salt Lake City, January 11, 2022 /GlobeNewswire/ — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of Rocky Mountain Movement Disorders Center’s clinical research site operations. CenExel Rocky Mountain Clinical Research (“CenExel RMCR”) is a...
CenExel Clinical Research Acquires California Neuroscience Research
Salt Lake City, January 10, 2022 /GlobeNewswire/ — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of California Neuroscience Research (“CenExel CNR”), a clinical research facility in Los Angeles with two decades of experience in neurological...